New cream aims to scratch the itch of eczema sufferers
NCT ID NCT07560618
First seen May 04, 2026 · Last updated May 16, 2026 · Updated 5 times
Summary
This study tests a cream called roflumilast for reducing itch in people with mild to moderate atopic dermatitis (eczema). About 40 participants aged 12 and older will use the cream daily for 4 weeks and report their itch and other skin sensations through a phone app. The goal is to see how the cream changes itch over time and what other feelings people have on their skin.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Integrative Skin Science and Research
Sacramento, California, 95815, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.